Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net (loss) income	$ (25,840)	$ 623
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Provision for credit losses	2,139	1,169
Depreciation and amortization	307	502
Amortization of deferred loan origination costs	384	370
Net accretion of premiums and discounts on available-for-sale securities	(226)	(674)
Accretion of purchase accounting marks on loans	(201)	(286)
Amortization of core deposit intangible	236	252
Accretion of premium on FHLB advances	0	(8)
ESOP compensation expense	149	137
Earnings on bank owned life insurance	(83)	(34)
Goodwill impairment	25,858	0
Change in assets and liabilities:
Net change in deferred taxes	(994)	(608)
Net change in accrued interest receivable	(648)	(806)
Net change in other assets	1,154	1,331
Net change in accrued expenses and other liabilities	(104)	1,972
Net cash provided by operating activities	2,487	4,235
Cash flows from investing activities:
Net change in loans receivable held for investment	(15,510)	(88,133)
Principal payments on available-for-sale securities	83,966	85,106
Purchases of available-for-sale securities	(117,874)	0
Purchase of FHLB stock	(8,771)	(136)
Proceeds from redemption of FHLB stock	12,360	0
Purchase of office properties and equipment	(134)	(129)
Purchases of bank owned life insurance	(20,000)	0
Net cash used in investing activities	(65,963)	(3,292)
Cash flows from financing activities:
Net change in deposits	103,806	(10,387)
Net change in securities sold under agreements to repurchase	9,508	16,323
Repayment of notes payable	0	(14,000)
Cash dividends paid - preferred	(2,250)	(817)
Proceeds from secured borrowings	0	2,367
Repayments of secured borrowings	(1,190)	(4,169)
Proceeds from FHLB borrowings	549,500	178,367
Repayments of FHLB borrowings	(637,532)	(176,743)
Net cash provided by (used in) financing activities	21,842	(9,059)
Net change in cash and cash equivalents	(41,634)	(8,116)
Cash and cash equivalents at beginning of the period	61,365	105,195
Cash and cash equivalents at end of the period	19,731	97,079
Supplemental disclosures of cash flow information:
Cash paid for interest	19,928	20,577
Cash paid for income taxes	0	317
Directors [Member]
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Director stock compensation expense	168	96
Employees, Excluding Directors [Member]
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Director stock compensation expense	$ 188	$ 199